System for High-Intensity Evaluation During Radiotherapy
Not Applicable
Completed
- Conditions
- Chemotherapeutic ToxicityRadiation Therapy Complication
- Registration Number
- NCT04277650
- Lead Sponsor
- Duke University
- Brief Summary
This quality improvement project will evaluate the implementation of a previously described intervention (twice per week on-treatment clinical evaluations) in a feasible fashion using a previously described machine learning algorithm identifying patients identified at high risk for an emergency visit or hospitalization during radiation therapy.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 311
Inclusion Criteria
• started outpatient radiation therapy with or without concurrent systemic therapy at Duke Cancer Center
Exclusion Criteria
- undergoing total body radiation therapy for hematopoetic stem cell transplantation
- undergoing therapy as inpatient
- treating physician who opted out of randomization
- completed radiation therapy prior to algorithm execution
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Number of unplanned emergency department visits or hospital admissions 6 months
- Secondary Outcome Measures
Name Time Method Number of missed clinical evaluation visits 6 months Number of acute care visits with listed reason as anemia, nutrition (including dehydration), diarrhea, emesis, infectious (including fever, pneumonia, and sepsis), nausea, neutropenia, pain category 6 months Number of unplanned emergency department visits or hospital admissions up to 15 days post radiation treatment up to 15 days post radiation treatment
Trial Locations
- Locations (1)
Duke Cancer Center
🇺🇸Durham, North Carolina, United States
Duke Cancer Center🇺🇸Durham, North Carolina, United States